/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

P

Pasquale Lombardi

Università Cattolica del Sacro Cuore(IT)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

106

Papers

1.3K

Citations

19

h-index

29

i10-index

Pasquale Lombardi is an academic researcher from Università Cattolica del Sacro Cuore. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Hepatocellular Carcinoma Treatment and Prognosis & Cancer Genomics and Diagnostics. The author has an h-index of 19, co-authored 91 publications.

ORCID: 0000-0001-6262-2161

Research Topics

Colorectal Cancer Treatments and Studies Hepatocellular Carcinoma Treatment and Prognosis Cancer Genomics and Diagnostics Health Systems, Economic Evaluations, Quality of Life Economic and Financial Impacts of Cancer

Papers by this author

works

New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis

2022 · Cancer Treatment Reviews · 39 citations

https://doi.org/10.1016/j.ctrv.2022.102377

Pasquale Lombardi Marco Filetti Rosa Falcone Rossella Di Bidino

Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study

2021 · British Journal of Cancer · 31 citations

https://doi.org/10.1038/s41416-021-01502-x

Valentina Gambardella Pasquale Lombardi Juan Antonio Carbonell‐Asins Noelia Tarazona

Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data

2021 · Clinical Colorectal Cancer · 22 citations

https://doi.org/10.1016/j.clcc.2021.06.002

Pasquale Vitale N. Zanaletti Vincenzo Famiglietti Vincenzo De Falco

Rationale for the use of metronomic chemotherapy in gastrointestinal cancer

2018 · Expert Opinion on Pharmacotherapy · 10 citations

https://doi.org/10.1080/14656566.2018.1512585

Roberto Filippi Pasquale Lombardi Ilaria Depetris Elisabetta Fenocchio

Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence

2025 · JHEP Reports · 5 citations

https://doi.org/10.1016/j.jhepr.2025.101431

Giulia Francesca Manfredi Claudia Angela Maria Fulgenzi Ciro Celsa Bernardo Stefanini

Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009–2023)

2025 · European Journal of Cancer · 2 citations

https://doi.org/10.1016/j.ejca.2025.115589

Giovanni Maria Iannantuono Charalampos S. Floudas Marco Filetti Tommaso Giovagnoli

Research topics

topics

Colorectal Cancer Treatments and Studies

Hepatocellular Carcinoma Treatment and Prognosis

Cancer Genomics and Diagnostics

Health Systems, Economic Evaluations, Quality of Life

Economic and Financial Impacts of Cancer

Chat about Author

Papers

Chat

Click to start Chat